Cytomedix Announces Multiple Presentations at the 24th Annual Symposium on Advanced Wound Care and Wound Healing Society
13. April 2011 08:00 ET | Cytomedix, Inc.
GAITHERSBURG, Md., April 13, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Reports 2010 Fourth Quarter and Full Year Financial Results
30. März 2011 17:16 ET | Cytomedix, Inc.
GAITHERSBURG, Md., March 30, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and...
Cytomedix Announces Issuance of Notice of Allowance for Patent Covering Separation Device for Proposed New AutoloGel System
17. März 2011 16:05 ET | Cytomedix, Inc.
GAITHERSBURG, Md., March 17, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care and...
Cytomedix to Host Fourth Quarter and Full Year 2010 Financial Results Conference Call on Thursday, March 31, 2011
16. März 2011 08:00 ET | Cytomedix, Inc.
GAITHERSBURG, Md., March 16, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis,...
Cytomedix Appoints Gary R. Otto as Director of National Accounts
10. März 2011 08:27 ET | Cytomedix, Inc.
GAITHERSBURG, Md., March 10, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care and...
Cytomedix to Present at the Lippert/Heilshorn Life Sciences & Medical Technologies Virtual Conference on February 17
15. Februar 2011 08:14 ET | Cytomedix, Inc.
GAITHERSBURG, Md., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix"), a leading developer of biologically active regenerative therapies for wound care,...
Cytomedix Receives CE Mark for Angel and activAT
10. Februar 2011 08:00 ET | Cytomedix, Inc.
GAITHERSBURG, Md., Feb. 10, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company" or "Cytomedix") today announced that the Company has been issued a CE marking certification for its...
Cytomedix CEO Issues Shareholder Update
02. Februar 2011 08:41 ET | Cytomedix, Inc.
GAITHERSBURG, Md., Feb. 2, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), ("the Company" or "Cytomedix") a leading developer of biologically active regenerative therapies for wound care,...
Cytomedix Provides Clarification for Investors Concerning Trading Under New Stock Symbol of CMXI
27. Januar 2011 08:30 ET | Cytomedix, Inc.
GAITHERSBURG, Md., Jan. 27, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) ("the Company" or "Cytomedix") provides clarification for investors regarding the trading of its common stock on the...
Cytomedix to Begin Trading Under New Symbol - CMXI - Effective January 26, 2011
25. Januar 2011 16:15 ET | Cytomedix, Inc.
GAITHERSBURG, Md., Jan. 25, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF) ("the Company" or "Cytomedix") announced today that its common stock will begin trading tomorrow, Wednesday,...